Alyeska Investment Group’s Applied Therapeutics APLT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-3,107,497
| Closed | -$1.52M | – | 555 |
|
|
2025
Q1 | $1.52M | Buy |
3,107,497
+400,000
| +15% | +$196K | 0.01% | 422 |
|
|
2024
Q4 | $2.32M | Buy |
2,707,497
+1,725,824
| +176% | +$1.48M | 0.01% | 455 |
|
|
2024
Q3 | $8.34M | Sell |
981,673
-983,973
| -50% | -$8.36M | 0.04% | 308 |
|
|
2024
Q2 | $9.18M | Buy |
1,965,646
+522,720
| +36% | +$2.44M | 0.05% | 279 |
|
|
2024
Q1 | $9.77M | Sell |
1,442,926
-1,161,793
| -45% | -$7.87M | 0.06% | 278 |
|
|
2023
Q4 | $8.73M | Sell |
2,604,719
-1,615,941
| -38% | -$5.41M | 0.06% | 268 |
|
|
2023
Q3 | $10.5M | Sell |
4,220,660
-210,746
| -5% | -$525K | 0.07% | 271 |
|
|
2023
Q2 | $5.67M | Buy |
4,431,406
+3,632,304
| +455% | +$4.65M | 0.04% | 313 |
|
|
2023
Q1 | $648K | Sell |
799,102
-468,950
| -37% | -$380K | 0.01% | 385 |
|
|
2022
Q4 | $964K | Sell |
1,268,052
-1,945,161
| -61% | -$1.48M | 0.01% | 352 |
|
|
2022
Q3 | $2.99M | Sell |
3,213,213
-1,144,477
| -26% | -$1.06M | 0.03% | 291 |
|
|
2022
Q2 | $4.13M | Buy |
+4,357,690
| New | +$4.13M | 0.05% | 314 |
|